David Hachuel, Mph
About David Hachuel, Mph
David Hachuel, MPH, is a co-founder of Kiwi Biosciences, where he has worked since 2021. He has a diverse background in entrepreneurship, finance, and technology, with experience at various organizations including Santander Bank and Bold Health.
Work at Kiwi Biosciences
David Hachuel serves as Co-Founder at Kiwi Biosciences, a position he has held since 2021. In this role, he has contributed to the company's mission of developing innovative health solutions. His work includes involvement in projects focused on enzyme supplements designed to enhance gut health. Under his leadership, Kiwi Biosciences was recognized as a finalist in the President’s Innovation Challenge by Harvard iLabs, highlighting the company's commitment to advancing health technologies.
Education and Expertise
David Hachuel has an extensive educational background. He earned a Master of Public Health (MPH) from Harvard T.H. Chan School of Public Health, where he studied Epidemiology from 2019 to 2021. He also holds a Master of Science (M.Sc.) in Computer and Information Science from Cornell University, completed between 2017 and 2019. Additionally, he studied Applied Information Science at Technion - Israel Institute of Technology, achieving another M.Sc. His undergraduate studies include a Bachelor of Science (B.Sc.) in Mathematics from New York University and a Bachelor of Business Administration (BBA) from Esade, where he transferred out after two years.
Background
David Hachuel has a diverse professional background spanning various roles in technology and finance. He began his career as a Quantitative Analyst at Santander Bank, N.A., where he worked from 2014 to 2016. He later served as a CCAR Quantitative Analyst and Technical Lead at the same institution. In 2020, he held the position of Chief Technology Officer at Bold Health. He co-founded auggi, which was acquired by Seed Health, and worked as a Student Mentor at the Martin Trust Center for MIT Entrepreneurship. In 2023, he took on roles as a Venture Partner at both Pioneer Fund and Orange Collective.
Achievements
David Hachuel has been recognized for his contributions to the health and technology sectors. He was part of a team that was named a finalist in the Pharma Industry Awards UK 2023. His collaborative efforts with Anjie Liu focused on providing solutions for individuals with dietary restrictions. Additionally, his involvement in the development of enzyme supplements has aimed to improve gut health, showcasing his commitment to innovation in health-related fields.